Clinical Trials
Clinical Research Trials at PCI
Our research department is committed to improving cancer care by giving patients access to a wide range of new therapies. We work closely with many top pharmaceutical and biotechnology companies who choose us to conduct important clinical trials. These trials are research studies involving human volunteers that test new medical approaches, including drugs, device, and diagnostic tools. Our partnerships with pharmaceutical and biotech companies allow us to offer advanced treatment options that are often not yet widely available, allowing eligible patients early access to promising new methods in cancer care.
Our work in clinical research is crucial to developing cancer therapies. By participating in carefully designed and well-run trials, we help assess the safety and effectiveness of new treatments. This support plays a key role in regulatory approval processes and expands the range of options available to patients around the world. These advancements have a real impact, leading to better outcomes, improved quality of life, and longer life expectancies for people facing various types of cancer.
One of PCI's research program's strengths is the close teamwork between our oncologists and the Clinical Research Department. We take a proactive, patient-focused approach by reviewing medical records, treatment histories, and individual health factors to find patients who may benefit from participating in clinical trials. Our team-based process ensures that each patient is carefully considered for therapies that match their specific diagnosis and treatment goals. In addition to finding suitable candidates, our research team provides thorough support throughout the clinical trial process. From the initial consultation and informed consent to ongoing monitoring and follow-up care, patients are guided by experienced professionals committed to their safety and well-being. This integrated approach not only improves the patient experience but also ensures the highest standards of clinical excellence. Through our dedication to research, innovation, and compassionate care, PCI continues to shape the future of oncology and bring new hope to patients and their families.
How do I find a clinical research trial at PCI?
For details regarding current clinical research trials, you can use our website to search our current trials or contact our research staff 678-298-3235.
What are the Phases of a Clinical Trial?
Clinical trials are conducted in phases. The phases are used to obtain specific information about the treatment or experimental drug.
Phase I trials: A small number of participants are used to test an investigational drug or treatment. The main focus is to determine the safety of the drug in humans. They evaluate the safe dose range and identify possible side effects from the drug/treatment.
Phase II trials: After completing the Phase I trials, the information is used to treat a slightly larger limited number of participants. Phase II uses the information gathered from Phase I to further evaluate the safety and effectiveness of the drug/treatment.
Phase III trials: The experimental treatment is given to a large group of participants in a variety of clinical settings to evaluate its safety, effectiveness and to monitor the side effects.
Phase IV trials: Once the drug has been approved by the FDA, this is when post marketing studies are conducted to continue to gain more information about the benefits and safety of the drug.
